Bcl10 antibody | knockout validation | Santa Cruz Biotechnology sc-5611
DOI
//dx.doi.org/10.13070/ko.en.6.1652
Date
2016-10-03

This is a knockout-validated antibody summary, based on the publication "Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Bcl10 antibody | knockout validation | Santa Cruz Biotechnology sc-5611 figure 1
Figure 1. Western blot of Bcl10 in WT and Bcl10-null (-/-) neutrophils. Actin was used as loading control. The image is representative of 3 independent experiments, from figure [1].
Antibody information

Antibody: Bcl10

Catalog number: sc-5611

Summary: Rabbit polyclonal IgG raised against epitope corresponding to amino acids 1-197 mapping at the N-terminus of Bcl10 of human origin. Recommended for detection of Bcl10 of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence, immunohistochemistry (paraffin) and ELISA. Also reactive with additional species, including equine, canine, bovine and porcine.

Company: Santa Cruz Biotechnology

Validation Method

Western blot

Sample

Bcl10–/– neutrophils were lysed in 100 mM NaCl, 30 mM Na-HEPES (pH 7.4), 20 mM NaF, 1 mM Na-EGTA, 1% Triton X-100, 1 mM benzamidine, freshly supplemented with 0.1 U ml−1 Aprotinin, 1:100 Mammalian Protease Inhibitor Cocktail, 1:100 Phosphatase Inhibitor Cocktail 2, 1 mM phenylmethylsulphonyl fluoride and 1 mM Na3VO4 (all from Sigma).

Primary incubation

0.2 ug ml−1

Secondary incubation

peroxidase-labelled secondary antibodies (GE Healthcare; dilution: 1:5,000).

Detection

ECL system (GE Healthcare) and exposed to X-ray film.

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Németh T, Futosi K, Sitaru C, Ruland J, Mocsai A. Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo. Nat Commun. 2016;7:11004 pubmed publisher